These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 12052815)

  • 1. Population-based Prostate Cancer Screening in Kazakhstan.
    Ishkinin Y; Zhylkaidarova A; Nurgaliyev N; Auyezova E; Oshibayeva A; Gorbunova N
    Iran J Public Health; 2017 Jul; 46(7):917-922. PubMed ID: 28845402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical practice. Screening for prostate cancer.
    Hoffman RM
    N Engl J Med; 2011 Nov; 365(21):2013-9. PubMed ID: 22029754
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for prostate cancer remains controversial.
    Neal DE; Donovan JL; Martin RM; Hamdy FC
    Lancet; 2009 Oct; 374(9700):1482-3. PubMed ID: 19664817
    [No Abstract]   [Full Text] [Related]  

  • 4. Storm over screening for prostate specific antigen. Give men facts on prostate cancer.
    Darracott Vaughan E; McLeod DG
    BMJ; 2002 Jun; 324(7350):1392. PubMed ID: 12053924
    [No Abstract]   [Full Text] [Related]  

  • 5. Moving towards shared decision making in prostate cancer screening.
    Hoffman RM; Helitzer DL
    J Gen Intern Med; 2007 Jul; 22(7):1056-7. PubMed ID: 17364242
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for prostate cancer: the case for.
    Malone P
    Ann R Coll Surg Engl; 2005 Mar; 87(2):88-9; discussion 88. PubMed ID: 15826414
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening for prostate cancer: a patient's view.
    N Z Med J; 2005 Apr; 118(1213):U1419. PubMed ID: 15843847
    [No Abstract]   [Full Text] [Related]  

  • 8. Storm over screening for prostate specific antigen. Summary of responses.
    Tonks A
    BMJ; 2002 Jun; 324(7350):1392. PubMed ID: 12053926
    [No Abstract]   [Full Text] [Related]  

  • 9. Advocates of PSA testing campaign to silence critics.
    Ferriman A
    BMJ; 2002 Feb; 324(7332):255. PubMed ID: 11823348
    [No Abstract]   [Full Text] [Related]  

  • 10. Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates.
    Tarone RE; Chu KC; Brawley OW
    Epidemiology; 2000 Mar; 11(2):167-70. PubMed ID: 11021614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilemmas in treating early prostate cancer: the evidence and a questionnaire survey of consultant urologists in the United Kingdom.
    Donovan JL; Frankel SJ; Faulkner A; Selley S; Gillatt D; Hamdy FC
    BMJ; 1999 Jan; 318(7179):299-300. PubMed ID: 9924055
    [No Abstract]   [Full Text] [Related]  

  • 12. The European Screening Study for Prostate Cancer.
    Schröder FH
    Can J Oncol; 1994 Nov; 4 Suppl 1():102-5; discussion 106-9. PubMed ID: 8853501
    [No Abstract]   [Full Text] [Related]  

  • 13. American Cancer Society--National Prostate Cancer Detection Project. Results from multiple examinations using transrectal ultrasound, digital rectal examination, and prostate specific antigen.
    Mettlin C; Murphy GP; Ray P; Shanberg A; Toi A; Chesley A; Babaian R; Badalament R; Kane RA; Lee F
    Cancer; 1993 Feb; 71(3 Suppl):891-8. PubMed ID: 7679042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Storm over screening for prostate specific antigen. Right to choose is important.
    Duckworth MJ
    BMJ; 2002 Jun; 324(7350):1392. PubMed ID: 12052815
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.